Propionate exerts neuroprotective and neuroregenerative effects in the peripheral nervous system
Proceedings of the National Academy of Sciences · 24.01.2023 · 120 (4)
DOI: 10.1073/pnas.2216941120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 20.01.2023. Verfasst von Thomas Grüter und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, St. Josef Hospital, Ruhr University Bochum, 44791 Bochum, Germany. Hauptthemen laut MEDLINE: Propionates, Histones. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
In inflammatory neuropathies, oxidative stress results in neuronal and Schwann cell (SC) death promoting early neurodegeneration and clinical disability. Treatment with the short-chain fatty acid propionate showed a significant immunoregulatory and neuroprotective effect in multiple sclerosis patients. Similar effects have been described for patients with chronic inflammatory demyelinating polyneuropathy (CIDP). Therefore, Schwann cell’s survival and dorsal root ganglia (DRG) outgrowth were evaluated in vitro after propionate treatment and application of H2O2 or S-nitroso-N-acetyl-D-L-penicillamine (SNAP) to evaluate neuroprotection. In addition, DRG resistance was evaluated by the application of oxidative stress by SNAP ex vivo after in vivo propionate treatment. Propionate treatment secondary to SNAP application on DRG served as a neuroregeneration model. Histone acetylation as well as expression of the free fatty acid receptor (FFAR) 2 and 3, histone deacetylases, neuroregeneration markers, and antioxidative mediators were investigated. β-hydroxybutyrate was used as a second FFAR3 ligand, and pertussis toxin was used as an FFAR3 antagonist. FFAR3, but not FFAR2, expression was evident on SC and DRG. Propionate-mediated activation of FFAR3 and histone 3 hyperacetylation resulted in increased catalase expression and increased resistance to oxidative stress. In addition, propionate treatment resulted in enhanced neuroregeneration with concomitant growth-associated protein 43 expression. We were able to demonstrate an antioxidative and neuroregenerative effect of propionate on SC and DRG mediated by FFAR3-induced histone acetylases expression. Our results describe a pathway to achieve neuroprotection/neuroregeneration relevant for patients with immune-mediated neuropathies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, St. Josef Hospital, Ruhr University Bochum, 44791 Bochum, Germany.
- Department of Neurology, Otto-von-Guericke University, 39120 Magdeburg, Germany.
ORCID-Profile: Thomas Grüter, Niklas Rilke, Seray Demir, Xiomara Pedreiturria, Katharina Lemhoefer, Barbara Gisevius, Anna Lena Fisse, Jeremias Motte, Kalliopi Pitarokoili
Zitieren
APA
Grüter, T., Mohamad, N., Rilke, N., Blusch, A., Sgodzai, M., Demir, S., Pedreiturria, X., Lemhoefer, K., Gisevius, B., Haghikia, A., Fisse, A. L., Motte, J., Gold, R., & Pitarokoili, K. (2023). Propionate exerts neuroprotective and neuroregenerative effects in the peripheral nervous system. Proceedings of the National Academy of Sciences, 120(4). https://doi.org/10.1073/pnas.2216941120
Vancouver
Grüter T, Mohamad N, Rilke N, Blusch A, Sgodzai M, Demir S, et al. Propionate exerts neuroprotective and neuroregenerative effects in the peripheral nervous system. Proceedings of the National Academy of Sciences. 2023;120(4). doi:10.1073/pnas.2216941120
BibTeX
@article{Grter2023,
author = {Grüter, Thomas and Mohamad, Nuwin and Rilke, Niklas and Blusch, Alina and Sgodzai, Melissa and Demir, Seray and Pedreiturria, Xiomara and Lemhoefer, Katharina and Gisevius, Barbara and Haghikia, Aiden and Fisse, Anna Lena and Motte, Jeremias and Gold, Ralf and Pitarokoili, Kalliopi},
title = {Propionate exerts neuroprotective and neuroregenerative effects in the peripheral nervous system},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
volume = {120},
number = {4},
doi = {10.1073/pnas.2216941120}
}
EUVIMED